Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Künstliche Intelligenz in der Kinderpneumologie – Chancen und unbeantwortete Fragen
0
Zitationen
1
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is already being used in most medical disciplines, including paediatric pneumology. This review describes current developments in AI-supported technologies and discusses their potential for the diagnosis and treatment of lung diseases in children and adolescents. The spectrum ranges from models for analysing respiratory sounds and the automated evaluation of medical imaging to systems for supporting clinical decisions. In particular, challenges in the adaptation of AI for paediatric populations are also described. Finally, open questions, such as the implementation of AI-based software in everyday clinical practice, will be discussed.
Ähnliche Arbeiten
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.776 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.909 Zit.
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 · 8.200 Zit.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · 6.477 Zit.
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
2016 · 5.704 Zit.